Study of CM313(SC) Injection in Systemic Lupus Erythematosus(SLE)
NCT06791772
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
150
Enrollment
INDUSTRY
Sponsor class
Conditions
Systemic Lupus Erythematosus
Interventions
BIOLOGICAL:
CM313 injection
BIOLOGICAL:
CM313 injection
DRUG:
Placebo
Sponsor
Keymed Biosciences Co.Ltd